masthead-news

News & Events

Categories

Reset Categories

Filter by Topics

AACR AMP ASCO Biomarker Discovery Bristol-Myers Squibb CDx Centre Leon Berard Clinical Biomarker CMDCAS Conference Conference Call Daiichi Sankyo Durviz ESHG FFPE Financial Results Forums Gamidor Genomeweb HTG HTG EdgeSeq ALKPlus Assay EU HTG EdgeSeq DLBLCL Cell of Origin Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq System HTGEdgeSeq IAP IHC Illumina Immuno-Oncology ISO 13485 IVD Merck KGaA Molecular Profiling Nasdaq Nature Research Custom Media Webcast Nature.com NGS NSCLC Patents Platform comparison PMWC Presentation QIAGEN Reports RNA-Seq Sequencing Symposium Thermo Fisher Transcriptome VERI/O Laboratory Services Webinar WIN Consortium WIN Symposium
Reset Filter Reset All

FFPE Tissue and the HTG EdgeSeq Oncology Biomarker Panel: A Low-Input, Extraction-Free Gene Expression Pilot Study

Join us Tuesday, September 20, 2016 for a Nature.org Webcast.

FFPE Tissue and the HTG EdgeSeq Oncology Biomarker Panel: A Low-Input, Extraction-Free Gene Expression Pilot Study

HTG will host a Nature.org Webcast with Dr. Katherine Pogue-Geile, Assistant Director of Molecular Profiling, National Surgical Adjuvant Breast and Bowel Project Foundation. This webcast will look at a pilot study, which examined different amounts of tissue input from 3 colorectal and 2 breast tumors down to 3.1 mm2, representing a quarter of the recommended input. The overwhelming majority of archival samples of cancer tissue are formalin-fixed, paraffin-embedded (FFPE).  Many FFPE samples, especially pre-treatment biopsy specimens, are too small to reliably extract sufficient RNA for gene expression analysis.    

Tuesday, September 20, 2016
9 AM PST, 12 PM EDT, 5 PM BST, 6 PM CEST

---

View our past webinars (new webinars are added as they become available after air date).

Posted on:

Return To List

Page last updated February 23, 2018